Quick Answer
RxSight, Inc. reported Long Term Debt of $0.00 for the year ending 2023.
- RxSight, Inc. showed a decrease of -100.0% in Long Term Debt from 2022 to 2023.
- This data is from RxSight, Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2024.
- XBRL data for this metric is available from 2020 to 2023 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $39.51 million | Q3 2021: $39.64 million | Q1 2022: $39.89 million | Q2 2022: $39.88 million | Q3 2022: $40.03 million | Q1 2023: $40.31 million | Q2 2023: $19.59 million | Q3 2023: $0.00.
- Over the full 4 years of available data (2020 to 2023), RxSight, Inc.'s Long Term Debt has declined by 100.0%.
- Historical annual values: Fiscal year 2023: $0.00 | Fiscal year 2022: $40.17 million | Fiscal year 2021: $39.76 million | Fiscal year 2020: $24.40 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: